UK cost body backs pricey Gilead hepatitis pill for some patients By: Reuters: Company News August 14, 2014 at 19:01 PM EDT * J&J cancer drug Zytiga rejected for use pre-chemotherapy Read More >> Related Stocks: Gilead Sciences Johnson & Johnson Rogers Corp